(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ACASEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ACASEN

ST13

US500000079275469

Class

5

Filing

79275469

Registration

6253452

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

06/05/2026

Trademark type

Word

Nice classes

5

Filing date

11/21/2019

Registration date

01/26/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/26/2021

Last transaction

06/05/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

25

Owner location

CH

Examiner

EISNACH, MICHAEL PATRICK

Law office

L40

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Alpinia Institute for Life Sciences AG
Alpinia Laudanum Institute of Phytopharmaceutical Sciences AG

Representatives

Frank W. Compagni Morriss O'Bryant Compagni Cannon, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Nutritional supplements for medical use; medicinesparticularly phytopharmaceutical productspharmaceutical preparations for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); active plant agents and plant extracts for medical useplant extracts for pharmaceutical purposes; pharmaceuticalveterinary and sanitary productspharmaceutical preparations for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); dietetic substances in the nature of food and beverages for medical usefood for babies; adjuvants for medical use; amino acids for medical use; anesthetics; analgesics; vermifuges; antibiotics; biological preparations for medical usebiological preparations for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); chemical products for medical usechemical preparations for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); chemical reagents for medical or veterinary use; chemico-pharmaceutical productschemical-pharmaceutical preparations for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); ferments for pharmaceutical use; hormones for medical use; medical infusions for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); medicines for dental usemedicines for treating dentalirritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); medicines for human medicinepharmaceutical preparations for treating irritable bowel syndromeconstipationdiarrhoeainflammatory bowel diseasecoeliac diseaseintolerance to FODMAPs (fermentable oligosaccharidesdisaccharidesmonosaccharides and polyols); radiological contrast substances for medical use; steroids

Publications

History of USPTO decisions and trademark events.

31 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/04/2026

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

01/26/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

05/23/2021

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

05/15/2021

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

04/29/2021

XXCR

GENERIC MADRID TRANSACTION CREATED

04/29/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/26/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

01/26/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/10/2020

PUBO

PUBLISHED FOR OPPOSITION

11/10/2020

GPNX

NOTIFICATION PROCESSED BY IB

11/08/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

10/21/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

10/21/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/21/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/06/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

10/06/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

10/06/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

10/06/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

10/06/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/25/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/24/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/24/2020

RFNT

REFUSAL PROCESSED BY IB

04/10/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/24/2020

RFRR

REFUSAL PROCESSED BY MPU

03/24/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/04/2020

CNRT

NON-FINAL ACTION WRITTEN

03/03/2020

DOCK

ASSIGNED TO EXAMINER

02/25/2020

MAFR

APPLICATION FILING RECEIPT MAILED

01/14/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/08/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/02/2020

Continuous trademark protection

Get notified about every new filing that threatens ACASEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.